Why is Elekta AB ?
- Poor long term growth as Operating profit has grown by an annual rate 0.83% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- ROCE(HY) Lowest at 2.43%
- INTEREST(Q) At SEK 110 MM has Grown at 15.79%
- DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -9.19%, its profits have risen by 11.4% ; the PEG ratio of the company is 1.2
- Even though the market (OMX Stockholm 30) has generated returns of 8.01% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -9.19% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Elekta AB for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at SEK 2,627 MM
Highest at 994.55
Fallen by -9.69% (YoY
Highest at 3.58%
Highest at 2.63%
Highest at SEK 5,156 MM
Highest at SEK 1,094 MM
Highest at 21.22 %
Highest at SEK 733 MM
Highest at SEK 654 MM
Lowest at 2.43%
At SEK 110 MM has Grown at 15.79%
Lowest at 0%
Lowest at SEK -1.01
Here's what is working for Elekta AB
Operating Cash Flows (SEK MM)
Operating Profit to Interest
Net Sales (SEK MM)
Operating Profit (SEK MM)
Operating Profit to Sales
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
Net Profit (SEK MM)
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Elekta AB
Interest Paid (SEK MM)
EPS (SEK)
DPR (%)






